Inventor · disambiguated record
Tomoaki Hasui
Also filed as: HASUI TOMOAKI
16 granted patents·3 pending applications·33 citations·filing 2006–2022
90Inventor score
Files withTAKEDA PHARMACEUTICALS CO6TANIGUCHI TAKAHIKO5TAKEDA PHARMACEUTICAL4FUKUMOTO SHOJI1HASUI TOMOAKI1
Top patents by PatentIndex Score
19 records- 0178US11407748B2Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor functionTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 9, 2022·1 cites·12 claims
- 0278US9150588B2Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitorsTANIGUCHI TAKAHIKO·Filed 2011·Granted Oct 6, 2015·5 cites·9 claims
- 0378US9090586B2Heterocyclic compoundYOSHIKAWA MASATO·Filed 2011·Granted Jul 28, 2015·5 cites·12 claims
- 0478US8563575B2Fused heterocyclic compoundsTANIGUCHI TAKAHIKO·Filed 2011·Granted Oct 22, 2013·4 cites·15 claims
- 0576US11447488B2Heterocyclic compoundsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 20, 2022·1 cites·9 claims
- 0675US9296746B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Mar 29, 2016·3 cites·13 claims
- 0775US8940758B2Fused heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jan 27, 2015·2 cites·17 claims
- 0875US8846713B2Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitorsTANIGUCHI TAKAHIKO·Filed 2011·Granted Sep 30, 2014·2 cites·2 claims
- 0974US9226921B2Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitorsTAKEDA PHARMACEUTICAL·Filed 2014·Granted Jan 5, 2016·2 cites·17 claims
- 1072US10112956B2Heterocyclic compounds having cholesterol 24-hydroxylase activityTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 30, 2018·1 cites·11 claims
- 1170US11939327B2Heterocyclic compoundsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Mar 26, 2024·0 cites·26 claims
- 1270US8883788B2Fused heterocyclic ring compoundHASUI TOMOAKI·Filed 2011·Granted Nov 11, 2014·4 cites·8 claims
- 1367US9624184B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Apr 18, 2017·1 cites·10 claims
- 1465US9579407B2Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammalsTANIGUCHI TAKAHIKO·Filed 2012·Granted Feb 28, 2017·1 cites·12 claims
- 1565US9029388B2Condensed heterocyclic compoundTANIGUCHI TAKAHIKO·Filed 2012·Granted May 12, 2015·1 cites·13 claims
- 1651US2010094000A1Pyrazole compoundsTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 1750US2023348435A11-((1h-pyrazol-4-yl)methyl)-3-(phenyl)-1,3-dihydro-2h-imidazol-2-one derivatives and related compounds as gpr139 antagonists for the treatment of e.g. depressionTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1837US2009253687A1Fused Heterocyclic Compounds and Their Use as Mineralocorticoid Receptor LigandsFUKUMOTO SHOJI·Filed 2006·Application pending·0 cites
- 1931US9029536B2Fused heterocyclic compoundsRAKER JOSEPH·Filed 2011·Granted May 12, 2015·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Tomoaki Hasui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →